James Eaton

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data for drug repurposing in Alzheimer’s disease

Drug repurposing offers a potential strategy to expand treatment options for conditions with limited therapies, but advancing repurposing candidates toward clinical implementation remains a challenge. Large-scale data, together with advanced genetic and epidemiological methods, m...